title: Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment.
authors.forename: S
authors.initials: S
authors.lastname: Nishida
authors.forename: K
authors.initials: K
authors.lastname: Hagihara
authors.forename: Y
authors.initials: Y
authors.lastname: Shima
authors.forename: M
authors.initials: M
authors.lastname: Kawai
authors.forename: Y
authors.initials: Y
authors.lastname: Kuwahara
authors.forename: J
authors.initials: J
authors.lastname: Arimitsu
authors.forename: T
authors.initials: T
authors.lastname: Hirano
authors.forename: M
authors.initials: M
authors.lastname: Narazaki
authors.forename: A
authors.initials: A
authors.lastname: Ogata
authors.forename: K
authors.initials: K
authors.lastname: Yoshizaki
authors.forename: I
authors.initials: I
authors.lastname: Kawase
authors.forename: T
authors.initials: T
authors.lastname: Kishimoto
authors.forename: T
authors.initials: T
authors.lastname: Tanaka
mesh_terms: D000686:Amyloidosis / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D003108:Colonic Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007077:Ileal Diseases / Q000188:drug therapy*; D008875:Middle Aged; D019947:Receptors, Interleukin-6
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D019947:Receptors, Interleukin-6; C502936:tocilizumab